Alcon Shares Fall 3% After Q4 Profit Miss, Sales Rise 9%
Alcon’s Q4 EPS and revenue missed analyst forecasts, sending shares down 3% despite a 9% year-over-year sales increase. Management issued guidance targeting up to 7% revenue growth in 2026.
1. Q4 Earnings and Revenue Performance
Alcon reported Q4 earnings per share and revenue below analyst expectations, with the profit shortfall attributed to pricing pressures and higher operational costs. Despite the miss, total sales rose 9% year-over-year, driven by solid demand across its surgical and vision care units.
2. Market Reaction
Shares declined 3% in the session following the earnings release as investors weighed the earnings shortfall against healthy top-line growth. Trading volume spiked as market participants reassessed Alcon’s near-term profitability outlook.
3. 2026 Guidance and Outlook
Management forecasted up to 7% revenue growth for 2026, emphasizing cost-efficiency initiatives and planned product rollouts to drive margin expansion. Investors will monitor execution on supply-chain improvements and new offerings to validate the guidance range.